about
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubesNF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 productionA bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-relOpposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1betaGroup-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection.Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle.1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310Pharmacological basis for dopamine D-2 receptor diversity.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.Late-onset Parkinsonism in NFκB/c-Rel-deficient miceGlutamatergic innervation of rat skeletal muscle by supraspinal neurons: a new paradigm in spinal cord injury repair.Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability.NF-kappaB dimers in the regulation of neuronal survival.Pharmacological targeting of the β-amyloid precursor protein intracellular domain.NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress.Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription.Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells.Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity.NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line.Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism.CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injuryNeuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivationα-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration.The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.The inhibitor of I kappa B alpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices.EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms.NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia.Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes.
P50
Q27308992-C6F6AC9E-264E-424A-AB96-71D7FA72946DQ28196676-9CCEE82E-6664-4BB5-8125-D96CB9531ECBQ28257961-AC784F49-67DE-47F3-967D-1E51E4DD3EE5Q28581717-702FFD98-9F0E-4525-9518-ACFBE78A6D1DQ33756939-E00A9301-F2F0-4DE2-8A08-160BF3FBB8B3Q33841591-112C2723-3A3B-455E-9AEC-F800DB6FD789Q34292783-32D0E160-8816-4E8E-8555-C6985093A338Q35282071-DDE0C972-DF89-42F7-BD33-EA5201D3BBDDQ35412397-B442547E-C144-4CA9-AC9C-8EBD15FE8875Q35627153-2B38DEFE-44D8-44F8-8762-DF376CF38E6FQ36218699-B36650C5-FFD7-4E2E-9F3A-2310C5E269D1Q36488468-946A1901-2C94-4AB5-A8CF-785BFE2EB2BDQ36541046-7268AAD4-9298-420A-B951-7872F1852D62Q37230760-7907D7F5-8AFA-45EE-A28F-C6EF9931B47DQ37352183-94AD5871-1761-4DDC-8DAB-9F3541413535Q37553228-59F9802C-ACC6-4EB8-9DBE-320B058D2F37Q37693126-D8C02A1B-703A-47C2-B5D1-C7F8F1E48147Q38009157-AA645AE2-59D0-4A6C-B6C8-5096E12AC414Q38358764-85907623-31BF-447F-9880-2F8708484C04Q38622485-E7A3C3E7-0480-4990-AE85-8A32CBB8BA4EQ38650395-56847DBC-7584-4F81-8D06-E7A5D547F83BQ39108546-91825604-B554-437A-9832-CE675BC29A61Q40032801-DC9C770C-0FBA-431A-B92C-0A5B6CE5E603Q40238974-46919D5D-F820-4FF6-9952-A6E5A9AA1725Q40437194-26EE8339-87CB-487E-BC7E-E0CFD0F9CC40Q40682294-6DB2D7C2-8D68-4F22-94B5-A11F3D795C6BQ41050568-DA92ACB9-EAA4-40AB-9A44-A2BF936849A9Q41754239-B0D0AD5A-6EA1-406E-84A1-257A4F70629BQ41878080-DE4CE34A-2E65-4134-B716-047607D6FF68Q41895193-435B5A6F-A3EE-491C-B752-1A6C9CC6F29FQ42476891-E2ADE366-02A6-45AB-A1EC-084685C8E700Q42480842-39B0B6E7-648C-4413-B52C-ECE714F60816Q42700405-E94B98B0-3FED-42E1-ABDB-E4E2DA987553Q43620009-9BBDCC63-A559-45D8-957F-85893DF8AEE1Q44264171-6A2121A6-41AF-413F-80C0-F1F8F87E8FD4Q45310365-3AA44D19-0335-4424-8D24-67EDBEDC9F1FQ45873617-10E0D93A-3635-4F91-A504-D507F827DCA7Q46065953-41F52724-B3CC-434F-A10D-CDB1A3A471A3Q46191668-3A5BB9CA-311C-4759-86F9-6E5FE089F470Q46806998-C8C89D8E-EF69-4F41-9EA6-A27F8DD30B29
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marina Pizzi
@ast
Marina Pizzi
@en
Marina Pizzi
@es
Marina Pizzi
@nl
type
label
Marina Pizzi
@ast
Marina Pizzi
@en
Marina Pizzi
@es
Marina Pizzi
@nl
prefLabel
Marina Pizzi
@ast
Marina Pizzi
@en
Marina Pizzi
@es
Marina Pizzi
@nl
P1053
K-2064-2016
P106
P1153
7006309937
P21
P31
P496
0000-0002-4857-5204